Status:
COMPLETED
Intensive tDCS for MDD: Feasibility Study
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This will be a prospective, open-label, single-arm study to determine the safety and feasibility of an intensive treatment of transcranial direct current stimulation (tDCS) for major depressive disord...
Detailed Description
This will be a prospective, open-label, single-arm study to determine the safety and feasibility of an intensive treatment of transcranial direct current stimulation (tDCS) for major depressive disord...
Eligibility Criteria
Inclusion
- Diagnosis of Major unipolar depression for at least 4 weeks meeting the criteria of the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5)
- Age between 18 to 65
- Minimum score of 17 on the GRID-Hamilton Depression Rating Scale (GRID-HAMD)
Exclusion
- Bipolar disorder,
- Psychosis
- Active substance use disorder (in the last 3 months)
- Personality disorder
- Neurocognitive disorder
- High risk of suicide
- Major comorbid medical or neurological condition
- Pregnancy
- Medical contraindications to tDCS:
- Ferromagnetic material in the skull
- Defect in the bone substance of the skull
- Dermatological condition (e.g. eczema, psoriasis, urticaria, dermatitis, acne, hyperhidrosis, folliculitis, rosacea, keratosis, herpes, infectious or neoplastic phenomenon, etc.)
- Skin lesion on the skull (ex: cuts, abrasions, rash, tattoos on the skull, piercings on the head, etc.)
Key Trial Info
Start Date :
February 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 16 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05194267
Start Date
February 2 2022
End Date
August 16 2023
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada, H2X 3J4